Clinical

Dataset Information

Cancer therapy with vaccination using HLA-A24-restricted peptide from RNF43:a phase I study in patients with unresectable colorectal cancer


ABSTRACT: Interventions: vaccination Primary outcome(s): safety Study Design: Single arm Non-randomized

DISEASE(S): Unresectable Colorectal Cancer

PROVIDER: 2616206 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR